Total Payments
$557.33
2024 Payments
$144.30
Companies
10
Transactions
32
Medicare Patients
2,653
Medicare Billing
$138,941
Payment Breakdown by Category
Food & Beverage$557.33 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $557.33 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $275.17 | 18 | $0 (2024) |
| Novo Nordisk Inc | $102.14 | 6 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $80.22 | 1 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $15.55 | 1 | $0 (2023) |
| Currax Pharmaceuticals LLC | $15.32 | 1 | $0 (2021) |
| Lilly USA, LLC | $14.81 | 1 | $0 (2021) |
| ARBOR PHARMACEUTICALS, INC. | $14.45 | 1 | $0 (2021) |
| Amarin Pharma Inc. | $14.27 | 1 | $0 (2022) |
| Abbott Laboratories | $13.06 | 1 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $12.34 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $144.30 | 5 | AstraZeneca Pharmaceuticals LP ($80.22) |
| 2023 | $179.11 | 12 | Amgen Inc. ($163.56) |
| 2022 | $104.30 | 7 | Novo Nordisk Inc ($45.52) |
| 2021 | $129.62 | 8 | Novo Nordisk Inc ($56.62) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Inflammation | ||||||
| 06/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Inflammation | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $80.22 | General |
| Category: Respiratory | ||||||
| 03/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Inflammation | ||||||
| 01/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Inflammation | ||||||
| 12/19/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Inflammation | ||||||
| 12/18/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Inflammation | ||||||
| 12/11/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Inflammation | ||||||
| 11/03/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Inflammation | ||||||
| 11/02/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Inflammation | ||||||
| 10/25/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Inflammation | ||||||
| 10/09/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Inflammation | ||||||
| 09/25/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: ANTIBIOTIC | ||||||
| 09/22/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Inflammation | ||||||
| 09/18/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Inflammation | ||||||
| 07/11/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Inflammation | ||||||
| 06/05/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Inflammation | ||||||
| 09/12/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Obesity | ||||||
| 05/17/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Inflammation | ||||||
| 04/26/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Cardio-renal | ||||||
| 04/11/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.87 | General |
| 03/21/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Cardiovascular | ||||||
| 02/18/2022 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Neuroscience | ||||||
| 02/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Diabetes | ||||||
| 10/01/2021 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 612 | 657 | $107,258 | $34,374 |
| 2022 | 14 | 803 | 850 | $133,992 | $43,602 |
| 2021 | 12 | 570 | 601 | $92,572 | $32,338 |
| 2020 | 15 | 668 | 743 | $104,094 | $28,628 |
Total Patients
2,653
Total Services
2,851
Medicare Billing
$138,941
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 271 | 302 | $63,420 | $20,208 | 31.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 113 | 117 | $14,040 | $5,534 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 78 | $11,700 | $3,575 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $11,840 | $3,396 | 28.7% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 22 | 22 | $1,430 | $725.46 | 50.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,860 | $664.81 | 23.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 67 | 74 | $1,184 | $162.80 | 13.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 14 | $784.00 | $108.48 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 330 | 363 | $76,230 | $27,389 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 123 | 126 | $18,900 | $6,063 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $14,720 | $4,168 | 28.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 88 | 91 | $10,920 | $2,765 | 25.3% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2022 | 26 | 26 | $1,690 | $900.09 | 53.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $2,860 | $863.97 | 30.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 20 | 20 | $2,000 | $422.17 | 21.1% |
| 90714 | Diphtheria and tetanus vaccine (7 years or older) | Office | 2022 | 12 | 12 | $804.00 | $267.94 | 33.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 21 | 24 | $1,344 | $226.14 | 16.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 73 | 78 | $1,248 | $167.51 | 13.4% |
| 90471 | Administration of vaccine | Office | 2022 | 12 | 12 | $660.00 | $120.45 | 18.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 15 | 15 | $600.00 | $109.81 | 18.3% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2022 | 12 | 12 | $744.00 | $74.76 | 10.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $1,272 | $65.89 | 5.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 231 | 249 | $53,290 | $18,697 | 35.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 95 | $14,250 | $5,439 | 38.2% |
| 87428 | Sarscov & inf vir a&b ag ia | Office | 2021 | 48 | 49 | $5,640 | $3,116 | 55.2% |
About Dawn Sampson, PA
Dawn Sampson, PA is a Physician Assistant healthcare provider based in Leland, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871676494.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dawn Sampson, PA has received a total of $557.33 in payments from pharmaceutical and medical device companies, with $144.30 received in 2024. These payments were reported across 32 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($557.33).
As a Medicare-enrolled provider, Sampson has provided services to 2,653 Medicare beneficiaries, totaling 2,851 services with total Medicare billing of $138,941. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Leland, NC
- Active Since 10/24/2006
- Last Updated 09/05/2018
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1871676494
Products in Payments
- Otezla (Drug) $255.68
- AIRSUPRA (Drug) $80.22
- Saxenda (Drug) $31.05
- Ozempic (Drug) $22.40
- Aimovig (Biological) $19.49
- NUZYRA (Drug) $15.55
- CONTRAVE (Drug) $15.32
- JARDIANCE (Drug) $14.81
- Horizant (Drug) $14.45
- Vascepa (Drug) $14.27
- Rybelsus (Drug) $13.78
- FreeStyle Libre (Device) $13.06
- Kerendia (Drug) $12.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Leland
Emily Crosson, Pa-C, PA-C
Physician Assistant — Payments: $2,266
Physician Assistant $2,266
Chad Snow, Pa, PA
Physician Assistant — Payments: $994.86
Physician Assistant $994.86
Ms. Stephanie Collins, Pa-C, PA-C
Physician Assistant — Payments: $991.46
Physician Assistant $991.46
Jesse Myers
Physician Assistant — Payments: $868.43
Physician Assistant $868.43
Jenna Hester, Pa-C, PA-C
Physician Assistant — Payments: $805.68
Physician Assistant $805.68
Allison Hindt, Pa-C, PA-C
Physician Assistant — Payments: $635.32
Physician Assistant $635.32